Connect with us
Novo Nordisk has entered independent research collaboration agreements with Omega Therapeutics and Cellarity to develop innovative therapeutic approaches for cardiometabolic diseases, with each company potentially receiving...
Alfasigma's Spanish subsidiary is expanding its facilities in Tortosa, Barcelona, to increase production capacity. The subsidiary, created in 2015 through the merger of Sigma-Tau and Alfa...
Spanish pharma companies started the year maintaining the red of the previous year. In Q1, the aggregate capitalization registered a drop of 10.57%, with values such...
Oryzon plans to maintain its share capital at €3.03 million and seek admission for new shares on Madrid, Barcelona, Bilbao, and Valencia Stock Exchanges. The biopharmaceutical...
The gross operating result (Ebitda) reached €97.1 million in the first half of 2023, 16% less than in the first six months of 2022. Operating income...
The demand for products indicated against diabetes has increased. Large groups in the sector announced new investment plans to grow in this segment. However, not everything...
This alliance focuses on said patent for the preparation of a preclinical antibody program against the IL-18 binding protein. Under the terms of the agreement, Compugen...
Authorities are focusing on addressing challenges related to integrating AI tools. The first initiative involves supporting AI in the life cycle of medicines. The Committee for...
Within the health sector, 20% of investment in R&D came from the ten largest companies by investment, which allocated €53.9 billion, €10 billion more than the...
According to the European Biotech index of Cphi, the largest pharmaceutical hub in the world, Barcelona is already the second best European location for investment in...
 |
|
 |  |
 |
|